Zynex Inc (ZYXI) is trading 10% higher at $8.58 today. The stock is moving on a positive earnings report, despite a down day in the health care sector.
Zynex reported that it's earnings per share and revenue beat analyst estimates. The also reiterated that their 2022 revenue guidance was still on track to meet the 150mil to 170mil goal.
Zynex Inc has been trading between a 52-week high of $14.09 and a 52-week low of $4.97. The stock has a market cap of $335 Million.
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex also has a blood volume monitor for use in hospitals and surgery centers.